News and Trends 29 Oct 2015
Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer
Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous) therapies, which are time-consuming and expensive, to instead produce an allogenic version available to all. So, what is CAR-T? You can read a more in-depth […]